Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Vaginal marijuana for menstrual cramps. Does it really work?

Jennifer Gunter, MD
Meds
February 11, 2016
Share
Tweet
Share

Foria wants you to know they are selling vaginal suppositories of THC (tetrahydrocannabinol) and CBD (cannabidiol) called Fiora Relief for menstrual cramps. Each suppository contains 60 mg of THC and 10 mg of CBD.

Foria claims they can treat the pain of menstrual cramps and endometriosis. Is this possible?

THC and cannabidiol (CBD) are compounds found in marijuana. The psychoactive (i.e., high) from marijuana is believed to be due to the THC, which can relax muscles and also cause euphoria and sedation as well as anxiety, paranoia, and dysphoria. Cannabidiol can stimulate receptors in the brain, reproductive, endocrine (hormone), gastrointestinal, and vascular systems. Some research suggests CBD may attenuate THC-induced tachycardia, euphoria, and anxiety (i.e. the bad parts of a high), but it’s not clear if that is really the case clinically. We have a lot to learn about these receptors and their role in pain and inflammation. Basically, we don’t know what we don’t know.

It is always hard to substantiate any claim about marijuana products due to the limited research. There is no study on THC and/or CBD for menstrual cramps or pelvic pain or endometriosis. If fact, the few studies on the reproductive tract are on rat uteri. If that doesn’t reassure you, I don’t know what will.

So what can we infer from the available research and general body of knowledge?

Oral and mucosal delivery of THC is different from smoking. Mucosal delivery (like vaginal suppositories or an oral spray) is a slower reveal to the brain than smoking. With edibles it is about 30 to 60 minutes for the drug to reach the brain.

We know a fair bit about mucosal delivery. Canada and the United Kingdom (and other countries) have the drug Sativex, a 1:1 ratio of THC and CBD to treat the muscle spasm associated with multiple sclerosis and pain from cancer. Each spray contains 2.7 mg delta-9-tetrahydrocannabinol (THC) and 2.5 mg cannabidiol (CBD). Eight sprays spread out throughout the day is very well-tolerated with no psychoactive effects.  A dose of 8 sprays over 20 minutes, so 21.6 mg, showed abuse potential. After Sativex is administered the THC and CBD appear in the bloodstream within 15 minutes. The maximum recommended dose is 12 sprays a day or 32.4 mg.

Absorption from the vaginal mucosa would likely be somewhere between the oral spray and ingestion, so between 15 and 60 minutes.

With oral administration many people consider 10 mg of THC to be one dose.

The dose of 60 mg of THC in the Fiora suppositories is significantly have higher than the recommended 32.4 mg maximum daily dose of Sativex.

It’s high doses of THC, much more common with modern strains, that takes people to the emergency department.

What about Foria’s claims?

The company says it’s product won’t get you high because “the medicine is administered as a vaginal suppository.” This makes no sense. Medications are absorbed from the vagina into the bloodstream and then from the bloodstream they go to the uterus and the brain and everywhere else that blood goes. This requires only a rudimentary knowledge of physiology. Medication doesn’t crawl up the vagina to the uterus and then just hang out avoiding circulation.

Fiora also claims the uterus has “more cannabinoid receptors than any part of the body except the brain.” I can find no study to support this assertion. Also, just because we have a receptor doesn’t mean that stimulating it produces a medicinal and safe effect. Opioids stimulate the all kinds of receptors and, of course, there is good and bad in that. Keep in mind that the role of endocannabinoid signaling in the human reproductive system is still largely not understood.

ADVERTISEMENT

What other effects could it have?

Vaginal THC and CBD could affect the vaginal ecosystem (the good bacteria).Again, untested. One study has linked marijuana use with colonization of the vagina with yeast.

Technically there is more than enough THC in Foria Relief vaginal suppositories to get you very high and even send you to the emergency department, although as vaginal absorption of THC is totally unstudied who really knows? Also, you are taking their word that this is the actual dose. The product might also contain not much of anything.

Why they decided to go with such a high dose is unknown as much lower doses can produce analgesia (pain relief), unless of course it’s not about the cramps after all.

If Foria Relief really does contain 60 mg of THC and absorption is between 15 and 60 minutes it’s hard to believe the goal isn’t to leave you paralyzed on the bed thinking menstrual cramps aren’t so bad after all.

I was going to suggest Maureen Dowd try them out and report back, but given all the unknowns and the dose I can’t recommend anyone use them. Not even for the New York Times.

Jennifer Gunter is an obstetrician-gynecologist and author of the Preemie Primer. She blogs at her self-titled site, Dr. Jen Gunter.

Image credit: Shutterstock.com

Prev

A quantitative analysis of the first year of internal medicine residency

February 11, 2016 Kevin 3
…
Next

Strategies for coping with the side effects of medications

February 11, 2016 Kevin 2
…

Tagged as: OB/GYN

Post navigation

< Previous Post
A quantitative analysis of the first year of internal medicine residency
Next Post >
Strategies for coping with the side effects of medications

ADVERTISEMENT

More by Jennifer Gunter, MD

  • The Ellen Show broadcasts potentially harmful information about ovarian cancer screening

    Jennifer Gunter, MD
  • Dear science: an appreciation

    Jennifer Gunter, MD
  • Are there too many female OB/GYNs?

    Jennifer Gunter, MD

Related Posts

  • Many questions remain about medical marijuana

    Steven Reznick, MD
  • The thorny side of medical marijuana

    Barbara Ficarra, RN, MPA
  • The problem with high-potency marijuana

    Libby Stuyt, MD
  • Qualifying conditions for medical marijuana

    Patricia Frye
  • Marijuana will not fix the opioid epidemic

    Kenneth Finn, MD
  • Doctors as the gatekeepers of marijuana is a race to the bottom

    John Schumann, MD

More in Meds

  • FDA delays could end vital treatment for rare disease patients

    G. van Londen, MD
  • Pharmacists are key to expanding Medicaid access to digital therapeutics

    Amanda Matter
  • How medicine repurposing enables value-based pain management and insomnia therapy

    Olumuyiwa Bamgbade, MD
  • Forced voicemail and diagnosis codes are endangering patient access to medications

    Arthur Lazarus, MD, MBA
  • From stigma to science: Rethinking the U.S. drug scheduling system

    Artin Asadipooya
  • How drugmakers manipulate your health from diagnosis to prescription

    Martha Rosenberg
  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Beyond burnout: Understanding the triangle of exhaustion [PODCAST]

      The Podcast by KevinMD | Podcast
    • Facing terminal cancer as a doctor and mother

      Kelly Curtin-Hallinan, DO | Conditions
    • Online eye exams spark legal battle over health care access

      Joshua Windham, JD and Daryl James | Policy
    • FDA delays could end vital treatment for rare disease patients

      G. van Londen, MD | Meds
    • Pharmacists are key to expanding Medicaid access to digital therapeutics

      Amanda Matter | Meds
    • Why ADHD in women requires a new approach [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 5 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • America’s ER crisis: Why the system is collapsing from within

      Kristen Cline, BSN, RN | Conditions
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • How early meetings and after-hours events penalize physician-mothers

      Samira Jeimy, MD, PhD and Menaka Pai, MD | Physician
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Beyond burnout: Understanding the triangle of exhaustion [PODCAST]

      The Podcast by KevinMD | Podcast
    • Facing terminal cancer as a doctor and mother

      Kelly Curtin-Hallinan, DO | Conditions
    • Online eye exams spark legal battle over health care access

      Joshua Windham, JD and Daryl James | Policy
    • FDA delays could end vital treatment for rare disease patients

      G. van Londen, MD | Meds
    • Pharmacists are key to expanding Medicaid access to digital therapeutics

      Amanda Matter | Meds
    • Why ADHD in women requires a new approach [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Vaginal marijuana for menstrual cramps. Does it really work?
5 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...